Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Mylan"


14 mentions found


Three times a day we would gather "off the desk," and I would have to defend every stock we owned. First, there's the obvious mistakes that we have made: Bausch Health and Foot Locker . To signify the changes, he renamed it Bausch Health in 2018, after the eye-care company Valeant bought for $8.7 billion five years earlier. We thought the IPO market would come back, and Bausch Health would win the lawsuit and all would be back on track. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
Persons: Jeff Marks, Karen Cramer, Cramer, Karen, Max Palevsky, It's, Joseph Papa, Clint Eastwood, Papa, Jim Cramer, Valeant, Bausch, Locker, Mary Dillon, Dillon, Wall, Emerson, Cristiano Amon, Laxman Narasimhan, Howard Schultz, Narasimhan, Benckiser, Kevin Johnson, Schultz, Johnson, it's, , Foot Locker, Jim Cramer's, Jim Organizations: Cramer &, Intel, Charitable Trust, Co, Starbucks, Bausch Health, Pharmaceuticals, Perrigo, Health, Norwich Pharmaceuticals, Former, Emerson Electric, Qualcomm, National, Eaton Corp, Broadcom, Palestine, PepsiCo, Nestle, Elliott Management, Emerson, CNBC, Getty Locations: China, , Israel, U.S, BHC, FL, Jinan, East China's Shandong province
Some around Biden agree Manchin may have a point in how to make the pitch. As Biden tries to assert the success of his presidency, Manchin says he shaped “everything” in the president’s agenda. “It’s been far less organized than he expected it to be” and “he doesn’t see a plan coming together,” a person familiar with Hogan’s thinking told CNN. “No matter what side of the fence you might be on, where you are for philosophically, we learned to navigate that,” he told CNN. Several anti-Trump Republicans who listened to Manchin’s speech told CNN they were happy to hear him.
Persons: CNN — Sen, Joe Manchin, Privately, Joe Biden, Donald Trump, Manchin, there’s, Vermont Sen, Bernie Sanders, Biden, Sanders, hadn’t, ” Manchin, , Trump, “ He’s, Larry Hogan, , “ It’s, , hasn’t, Connecticut Sen, Joe Lieberman, Pat McCrory, Mark Penn, Nancy Jacobson, Ryan Clancy, Chris Christie, Heather Bresch, Bresch, Tom Reed, ” Reed, Bernie Sanders Manchin’s, codifying Roe, Wade, Roe, Machin, Saint Anselm Organizations: CNN, West Virginia Democrat, Biden, Trump, Democratic, Trump Republicans, Senate, White House, Washington, Democrat, Republican, North Carolina Gov, White, Representatives, Justice Department, New, New York Rep, Manchin, Saint Anselm College Locations: New Hampshire, South Carolina, Georgia, Vermont, Maryland, Dallas, Connecticut, North Dakota , New York , Florida , Texas, Hawaii, New Jersey, Manchin’s New Hampshire, Texas, Manchester, Washington, Saint, Unfazed
Many of the patents at issue in the Food and Drug Administration's Orange Book listing of approved products were for devices such as asthma inhalers and epinephrine autoinjectors, the FTC said. "Wrongfully listed Orange Book patents by pharma companies can raise drug prices for Americans, harm fair competition, and delay better drugs," FTC Chair Lina Khan said on X, formerly known as Twitter. The Orange Book identifies drugs and products that the FDA has deemed safe and effective. The FTC says companies sometimes improperly list patents in the Orange Book that can delay market entry of lower priced generics. AbbVie was informed the FTC would dispute four patents in the Orange Book having to do with Restasis Multidose, eye drops used for chronic dry eye.
Persons: Andrew Kelly, Lina Khan, Boehringer Ingelheim, Mylan, AbbVie, Restasis, Diane Bartz, Patrick Wingrove, Bill Berkrot Organizations: Food and Drug Administration, FDA, REUTERS, AstraZeneca, GSK, U.S . Federal Trade Commission, Food, FTC, pharma, Thomson Locations: White Oak , Maryland, U.S, WASHINGTON, Israel, Viatris
Flags with the Novo Nordisk logo flutter outside their Danish company's offices in Copenhagen, Denmark, September 26, 2023. The office's Patent Trial and Appeal Board denied the requests by Mylan Pharmaceuticals, which is owned by Viatris (VTRS.O), to review the validity of the Wegovy and Ozempic patents. A spokesperson for Novo Nordisk said the company will "vigorously defend" its intellectual property. Novo has filed several U.S. patent lawsuits against companies including Pennsylvania-based Viatris that are seeking to market generic versions of the drugs. Viatris has separately asked a West Virginia federal court to invalidate the patents as part of the litigation.
Persons: Tom Little, Wegovy, Ozempic, Mylan, Viatris, Novo's Wegovy, Novo, Blake Brittain, Patrick Wingrove, Will Dunham, David Bario Organizations: Novo Nordisk, Danish, REUTERS, Rights, U.S . Patent, Mylan Pharmaceuticals, Viatris, West, Thomson Locations: Copenhagen, Denmark, Pennsylvania, West Virginia, Washington, New York
Circuit Court of Appeals on a 2-1 vote granted a request by Edward Blum's American Alliance for Equal Rights to temporarily block Fearless Fund from considering applications for grants only from businesses led by Black women. Blum's group asked the court to do so while it appealed a judge's Tuesday ruling denying it a preliminary injunction blocking Fearless Fund from moving forward with its "racially exclusive program." Fearless Fund did not immediately respond to requests for comment. According to the Fearless Fund, businesses owned by Black women in 2022 received less than 1% of the $288 billion that venture capital firms deployed. It also provides grants, and Blum's lawsuit took aim at its Fearless Strivers Grant Contest, which awards Black women who own small businesses $20,000 in grants and other resources to grow their businesses.
Persons: Ben Crump, Arian Simone, Ayana Parsons, Mylan Denerstein, Alphonso David, Eduardo Munoz, Edward Blum's, Blum's, Grant, Robert Luck, Andrew Brasher, Thomas, Donald Trump, Blum, JPMorgan Chase, Strivers, Nate Raymond, Alexia Garamfalvi, Andrea Ricci Organizations: Fund, REUTERS, Supreme, Circuit, Edward Blum's American Alliance for Equal Rights, U.S, District, American Alliance for Equal Rights, Harvard University, University of North, JPMorgan, Bank of America, MasterCard, Thomson Locations: New York, U.S, Atlanta, Texas, University of North Carolina, Black, Boston
Wall Street is coming off a losing week, with the Nasdaq Composite Index closing 1.9% lower, the S & P 500 falling 1.3% and the Dow Jones Industrials shedding 0.8%. By contrast, here are the most oversold stocks in the S & P 500: Alaska Air Group has the highest projected upside on the list (+60%), continuing last week's trend . Walgreens Boots Alliance is another of the most oversold companies in the S & P 500. Viatris was the most oversold company in the S & P 500 with a 14-day RSI less than 7. Discount retailers Dollar Tree and Dollar General as well as chemical manufacturer FMC are also among the most oversold companies in the S & P 500.
Persons: Dow Jones, Piper, Baker Hughes, Viatris, Pfizer's Upjohn Organizations: Federal Reserve, Nasdaq, CNBC Pro, Technology, Intuit, IBM, Accenture, CNBC, Autodesk, Verisk, Alaska Air Group, Walgreens Boots Alliance, Walgreens, Wall Street, FMC Locations: Seattle, Mylan
The monitor, Mylan L. Denerstein, filed a report in federal court in Manhattan on Monday detailing what she described as unlawful policing. Earlier versions of the units were responsible for a disproportionate number of police shootings, and they were disbanded in 2020. Mr. Adams reinstated and renamed them after he took office last year, but critics were skeptical that they could be run without racially profiling young men of color, as previous units had. Almost all of the stops made by the rebranded “neighborhood safety teams” analyzed in the report — 97 percent — were of Black or Hispanic people, and 24 percent of the stops were unconstitutional. Of 230 car stops included in the sample, only two appear to have turned up weapons, the report said.
Persons: Eric Adams, Denerstein, frisk, Adams Organizations: New York Police, Police Locations: Manhattan
[1/2] Sanofi logo at the company's headquarters during the annual results news conference in Paris, France, February 4, 2022. Sanofi in 2009 acquired the rights to Auvi-Q, an epinephrine auto-injector intended to compete with EpiPen. Injection of epinephrine is used to treat serious and sometimes life-threatening allergic reactions to foods, medications, bee stings and other causes. Circuit Court of Appeals last July agreed, noting that the exclusive contracts in question were "a normal competitive tool within the epinephrine auto-injector industry." The 10th Circuit added that Sanofi could have competed on those terms, but instead chose initially to market Auvi-Q as a more expensive, premium product.
"We believe that Africa's growth will be a key driver of global growth over the coming decades," a senior Treasury official told reporters. But some African countries, including Zambia, have soured on Chinese lending and are looking for alternatives, experts say. Yellen has criticized Beijing - now the world's largest creditor - for not moving quickly to restructure the debt of poor countries in Africa. The topic will be a key issue when she visits Zambia, the Treasury official said. Biden in December proposed that the African Union be included in the Group of 20 major economies to give African countries a bigger seat at the table.
The problem was the Neris had switched to a new, high-deductible health insurance plan to save money. The 2010 Affordable Care Act expanded access to health insurance, so companies were faced with covering more people than ever before. But the epinephrine auto-injectors — which deliver a shot of epinephrine and are the only emergency medicine available for life-threatening allergic reactions — usually are not. But AHIP (formerly known as America’s Health Insurance Plans), a group that represents such companies, said drug manufacturers are to blame. Fight it with your health care provider, fight it with your insurance company.”“No almost never means no in health insurance,” he said.
The Justice Department is pursuing an insider-trader case involving an executive at Viatris, a healthcare company. A top technology executive at the healthcare company Viatris Inc. was charged with sharing illicit stock tips that netted millions of dollars for a friend who traded on them, according to the Justice Department. Ramkumar Rayapureddy, the global chief information officer at Viatris , shared undisclosed information about a regulatory drug approval, his employer’s financial results and a planned merger with a division of Pfizer Inc., authorities said. When he worked at Mylan NV, a predecessor company to Viatris, Mr. Rayapureddy allegedly leaked the information to a friend, Dayakar Mallu, according to an indictment.
A former pro athlete and first-gen law student, he started networking before school started. David Ako Abunaw III is a former professional athlete and a student at the University of Pennsylvania's law school. But I feel like it's common for law students to be very type A, so that's never going to be me. Networking with law firms was key to getting early interviews and offersI started networking before law school. I spoke with people at several law firms, either UPenn graduates or people I had something else in common with.
Randy Mastro, a fixture at Gibson Dunn since 1998, is leaving the firm, four people told Insider. Star attorney Randy Mastro is leaving Gibson Dunn & Crutcher after more than 20 years, four people told Insider. Mastro has spent more than two decades at Gibson Dunn, which he first joined in 1989. By 2014, Chevron had run up a $32 million tab with Gibson Dunn, a bill it tried to make Donziger pay, according to Reuters. Do you know Randy Mastro or more about why he left Gibson Dunn?
Directorul general al Agenției Medicamentului și Dispozitivelor Medicale, Eremei Priseajniuc, a semnat vineri, 9 octombrie, o autorizație pentru importul a încă 5 000 de flacoane de Remdesivir, acesta fiind primul medicament autorizat în SUA și UE pentru tratamentul COVID-19. Potrivit reprezentanților Agenției Medicamentului și Dispozitivelor Medicale, acest lot de Remdesivir, cu denumirea comercială Desrem, produs de compania farmaceutică Mylan, Olanda, este importat de Tetis International CO SRL și este programat să ajungă la Chișinău în perioada imediat următoare. În Republica Moldova, preparatul Remdesivir este prevăzut în Protocolul clinic național provizoriu „Infecția cu coronavirus de tip nou”, utilizat în tratamentul pacienților infectați cu virusul SARS COV-2. La 8 septembrie, Agenția Medicamentului și Dispozitivelor Medicale a autorizat importul în premieră a circa 2 000 flacoane de Remdesivir, cu denumirea comercială Covifor. La 7 octombrie, Comisia Europeană a anunţat că a convenit cu societatea farmaceutică americană Gilead achiziţia a peste 20.000 de doze suplimentare de Remdesivir, încercând astfel să acopere deficitul în aprovizionarea cu acest medicament antiviral cu care se confruntă statele Uniunii Europene.
Organizations: Mylan, Agenția Medicamentului, Comisia Europeană, Uniunii Europene Locations: SUA, UE, Olanda, Chișinău, Republica Moldova
Total: 14